chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had a 16 year old patient who received the first dose of the Moderna covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had a 16 year old patient who received the first dose of the Moderna covid-19 vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had a 16 year old patient who received the first dose of the Moderna covid-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (had a 16 year old patient who received the first dose of the Moderna covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment medications were provided
Case number PHEH2015US023626, is an initial spontaneous report from a nurse received on 10 Nov 2015. This report refers to a 51 years old female patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: unknown) in 2014. After vaccination the patient experienced total body alopecia which started in Oct 2014. Her hair had not re grown and she was concerned about taking this season's FLUVIRIN vaccine. Final outcome of the event was not recovered. Seriousness and causality of the event was not reported. Seriousness assessment of "total body alopecia" was upgraded based on information in the source document. Following an internal review on 19 Nov 2015 of the data received on 10 Nov 2015, it was found that the initially case was wrongly assessed as non-serious. Hence the case was upgraded.
had a sudden headache come on about 1 hour after shot, but it went away within about 1 more hour...woke up at 5:00 this morning (day after shot) with horrible pain from shoulder all the way to finger tips....fell back asleep, woke again at 7:30 with the same symptoms got up and tried moving the arm (with pain) went ahead and used arm and read reactions and what to do...tried to use arm, after about 1 hour of trying to use arm the pain is just over the injection where there is a grapefruit size hard spot with intense pain.  Will continue to try to move the arm and use cold compresses and drink water as the organization site suggested. Pain is not just in upper arm with majority of pain in that grapefruit size area.
Golf ball sized swelling in right armpit Rash on right arm (on the opposite side of the arm from the injection site) Pain from rash and armpit Headache Fatigue
Developed generalized urticaria 24 hrs. after vaccination. No other known exposures. No other symptoms or physical findings. Pt. seen day of rash and started on BENADRYL.
Piercing tinnitus. Hearing became a bit muffled after a few days and turned into full blown, piercing, debilitating tinnitus within a week. Never had any hearing problems before in my life and my senses have always been acute.
Systemic: Hyperventilation-Severe, Systemic: Shakiness-Medium, Additional Details: Patient left after receiving the vaccine then the patient's son came back and she was having trouble breathing, the store manager called 911, the patient was given a blanket to keep warm and she drink some water while waiting in the car. The ambulance came, EMT techs took a vitals and transported her to the hospital
injection site turned pink; hives appeared at the site of the injection; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching), VACCINATION SITE URTICARIA (hives appeared at the site of the injection) and VACCINATION SITE ERYTHEMA (injection site turned pink) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included CLL (Chronic lymphocytic leukaemia).   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (Itching). On 25-Apr-2021, the patient experienced VACCINATION SITE URTICARIA (hives appeared at the site of the injection). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (injection site turned pink). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching) and VACCINATION SITE ERYTHEMA (injection site turned pink) was resolving and VACCINATION SITE URTICARIA (hives appeared at the site of the injection) had resolved.            No relevant concomitant medications were provided. Treatment activities for event was also done with Triple antibiotic ointment. The action taken for mRNA-1273 was not applicable.
I received the first COVID19 vaccine in the series on April 22 and the second on May 20. On July 23, I reported to my doctor that I was experiencing swollen lymph nodes. I know this started before July 23, but I did not note the exact date. These were primarily in my left arm pit, but at times, on my neck and in my right arm pit. The area would be tender for about a day and then resolve. In August, this happened six times, then it became less frequent. It briefly became more frequent in October following my flu vaccine.
Pt. received ADACEL 11-7-16 and developed an arthus-type reaction in her right arm.
UTI; cough; A spontaneous report was received from a consumer concerning a patient who developed/experienced  hospitalization for 7 days  UTI, cough, MedDRA PT: hospitalization, urinary tract infection, cough   The patient's medical history was not provided.   The patient received their first of two planned doses of mRNA-1273 .Batch number not provided  Treatment information was unknown. The patient scheduled to received the second shot of the vaccine.  Patients reports having a bad reaction to the first shot; starting cough, and ended up with a UTI and ended up in the hospital for 7 days.  Action taken with mRNA-1273 in response to the events were unknown. The outcome of the events were not reported.; Reporter's Comments: This case concerns a female of unknown age who experienced a "bad reaction to the first shot" and then was hospitalized with a serious unexpected event of UTI and a NS unexpected event of cough. The events occurred with unknown latency after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown.  Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
In beginning of March 2021, noticed blood pressure was elevated. My physician changed my medication one in the afternoon and one in the morning, but after I had the second vaccine she adjusted my  medication dosage up. In the middle of March my blood pressure suddenly dropped, and I went to the ER, they did cardiogram levels, EKG, chest x-rays, echocardiogram, kept me over night, because they thought I might have had a stroke, but I did not.  I believe that it was the change in my blood pressure medication.  My blood pressure elevation went up to 180 for diastolic and was running between 120 or 140 with my blood pressure medication.  In April 2021, I started feeling I was getting a cold, went to a clinic, saw a NP gave me medication and four days later I went again to the ER. On 04-21-2021  at the ER, all exams were repeated, EKG?s, found I had bilateral pneumonia, heart blockage.    I am a nurse scientist,  I think they survey is not written correctly, my opinion, the instructions should be clearer to any person reporting an symptoms.
Redness surrounding vaccination site 90mm x 75mm. Prior reaction last year to Flu vaccine with 1/2 on redness area.
Arm soreness; This is a spontaneous report from a contactable consumer (the patient). A 74-years-old patient of an unspecified gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9264), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Medical history included diabetic from an unknown date. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced arm soreness after second dose of vaccine. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Racing and irregular heart beat - being tested and treated by cardiologist Severe and constant abdominal pain - waiting for GI appointment for treatment Dizziness, lightheaded from sitting to standing - heart rate monitored for 2 weeks by cardiologist  Lockjaw - treated by a massage therapist Chronic sinus pressure and post nasal drip - being treated by ENT, waiting on CAT scan
Diarrhea; Chills; Cough; Sneezing; Nausea; This is a spontaneous report received from a contactable consumer (patient). A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248, expiry date: unknown), via an unspecified route of administration on the left upper arm, on 30Jan2021, at single dose, for COVID-19 immunization, at a nursing home. Medical history included ongoing allergies which the patient was diagnosed before having the vaccine. There were no concomitant medications. The patient did not receive prior vaccinations within 4 weeks. On 30Jan2021, 2 hours after the vaccination, the patient experienced nausea. On 31Jn2021 at 03:00, the patient experienced chills, was coughing and sneezing. She stated that she was not coughing constantly, and it comes off and on. On 02Feb2021, the patient experienced diarrhea. She called her doctor and treatment included Tylenol and inhaler if needed. Her doctor would not give her prednisone so her lungs could get strong. The patient stated that she was scheduled to get her second dose on 20Feb2021. The patient recovered from nausea on 31Jan2021; was recovering from chills, cough and sneezing; and has not recovered from diarrhea.
Patient was given 2nd dose of the series too early; administered 23 days after 1st dose.
Resident was given the bivalent booster dose instead of primary series.  She has no record of receiving a primary series in regulatory authority or her medical records.
pt recv vax in 1994 & devel bilat symmetrical ascending arthralgia from ankles to shoulders;sx lasted about 1 wk & then resolved;
Injection site irritation; injection site bruising; Vaccination site swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE IRRITATION (Injection site irritation), INJECTION SITE BRUISING (injection site bruising) and VACCINATION SITE SWELLING (Vaccination site swelling) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Hidradenitis suppurativa.    The patient's past medical history included Hidradenitis (Hidradenitis suppurativa outbreak on right side of groin area.) and Hysterectomy (Outpatient surgery and recovered) in February 2021. Concurrent medical conditions included Arthritis since 2016 and Alcohol use (A couple of glasses of wine a week). Concomitant products included ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for Acid reflux (esophageal), BUPROPION for Anxiety and Depression, POTASSIUM CHLORIDE, LISINOPRIL, FUROSEMIDE SODIUM (LASIX [FUROSEMIDE SODIUM]), LABETALOL, HYDROCHLOROTHIAZIDE and ROSUVASTATIN CALCIUM (CRESTOR) for Blood pressure high, HYOSCYAMINE for Irritable bowel syndrome.   In July 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg once a week. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Vaccination site swelling). On an unknown date, the patient experienced INJECTION SITE IRRITATION (Injection site irritation) and INJECTION SITE BRUISING (injection site bruising). At the time of the report, INJECTION SITE IRRITATION (Injection site irritation) and INJECTION SITE BRUISING (injection site bruising) was resolving and VACCINATION SITE SWELLING (Vaccination site swelling) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, Biopsy: negative (Negative) Negative. On 04-Mar-2021, Blood test: unknown (normal) No value reporter.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Rash began upper abdomen evening of 09082022. Morning of 09092022, rash covered abdomen, back, upper arms, thighs. Rash spreading rapidly, moving up neck, past elbows and knees.
I have been having a lot of numbness throughout the area where I received the Pfizer shot. Today, Sunday 9/5/21 by entire left side was numb starting from the left side of my face, down to my left arm all the way through my left leg.
No adverse event; child was suppose to receive the Moderna bivalent booster but instead they got the Moderna primary series for 6 to 11 years old at the; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (child was suppose to receive the Moderna bivalent booster but instead they got the Moderna primary series for 6 to 11 years old at the) and NO ADVERSE EVENT (No adverse event) in a 9-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018C22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Flu vaccine. Past adverse reactions to the above products included No adverse event with Flu vaccine.    On 07-Dec-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Dec-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG PRODUCT ADMINISTERED (child was suppose to receive the Moderna bivalent booster but instead they got the Moderna primary series for 6 to 11 years old at the). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (child was suppose to receive the Moderna bivalent booster but instead they got the Moderna primary series for 6 to 11 years old at the) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (child was suppose to receive the Moderna bivalent booster but instead they got the Moderna primary series for 6 to 11 years old at the).    The patient receives other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant medications was reported. Dose of Moderna vaccine was reported as 0.25 dose. No treatment medications was reported.
Shortly after receiving the Moderna COVID-19 Vaccine (Within minutes) she complained of the injection site and that arm of feeling warm.  Upon further inspection, her arm was warm to the touch and was red.  Patient could feel warmth from inside and we could also feel the warmth  with touch.  She stayed 15 minutes and we monitored the site.  There was no further reaction.  The patient had been offered Benadryl and declined.  This will be  notated for her second dose and will pre-treat with benadryl if needed.
little additional tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (little additional tiredness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy (Aspirin allergy), Drug allergy (Cortisone allergy) and Hypothyroidism (Low Thyroid). Concomitant products included LEVOTHYROXINE for Hypothyroidism, MULTIVITAMIN [VITAMINS NOS], GLUCOSAMINE, FISH OIL and ZINC for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced FATIGUE (little additional tiredness). At the time of the report, FATIGUE (little additional tiredness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided by reporter.
Still have small red spots at both injection sights; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Mar2021 13:30 (Lot number: EN6204) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), outcome "not recovered", described as "Still have small red spots at both injection sights".  No follow-up attempts are possible. No further information is expected.
Pt received immunizations on 3/8/04. Mom called our office on 3/11/04 and reported pt's L arm red, swollen, warm, and tender to touch (approximately 3-4 inches around). No fever. Mom advised to try warm compresses, and Tylenol as needed. Advised to call back in 24 hrs if no better, sooner if worse.
Signs/Symptoms: Tingling in back, neck and head. Itching in legs and back.  RESOLVED!
arm was a little warm around the injection site; arm was reddish around the injection site; arm was itchy around the injection site; arm was slightly swollen around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm was a little warm around the injection site), VACCINATION SITE ERYTHEMA (arm was reddish around the injection site), VACCINATION SITE PRURITUS (arm was itchy around the injection site) and VACCINATION SITE SWELLING (arm was slightly swollen around the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE WARMTH (arm was a little warm around the injection site), VACCINATION SITE ERYTHEMA (arm was reddish around the injection site), VACCINATION SITE PRURITUS (arm was itchy around the injection site) and VACCINATION SITE SWELLING (arm was slightly swollen around the injection site). At the time of the report, VACCINATION SITE WARMTH (arm was a little warm around the injection site), VACCINATION SITE ERYTHEMA (arm was reddish around the injection site), VACCINATION SITE PRURITUS (arm was itchy around the injection site) and VACCINATION SITE SWELLING (arm was slightly swollen around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported Treatment medications was not provided
I felt fine for a couple weeks, then I develop a sore on my left big toe that would not heal. I went to the doctor on 07/05/2021 and was prescribed antibiotics. I went back in August of 2021 and my toe had to be removed. I then developed a blister on my pinky toe on 02/24/2021 and it had to be removed along with the metatarsal bone. I feel weak and if I get a cut or scratch it takes forever to heal. I am currently taking clindamycin and gentamicin, metformin, gabapentin, and insulin (Novolin).
Per patient 2-3 days after he received his Moderna booster he experience lost of taste and smell.  Had nose drips with a slight cough.  The nose drip and lost of taste and smell still lingers.  He has taken 3-4 home repid COVID test that has came back negative.  Stated that after he eats his mouth has a greasy sensation.  Almost like after you ear fries and have the after taste.  No other symptoms.
6-7 hours later developed erythema all over the body, hands swelled up, generalized pruritis, tongue swelled and felt like larynx was swelling. No wheezing, but chest felt tight. 12/30/09 ER records received for date 10/12/09. DX: allergic reaction. Presenting c/o pruritis, rash, tongue swelling. Assessment: diffused erythmatous rash.
Headache; Swollen throat; This is a spontaneous report from a non-contactable consumer (patient). This 33-year-old non-pregnant female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: EN6201) via an unspecified route of administration on 11Feb2021 at 04:00 PM (at 33-year-old) on left arm as dose 1, single for COVID-19 immunization. The medical history of the patient included latex allergy, nickel allergy, Gluten intolerance and dairy intolerance. The patient received other medications in two weeks. It was mentioned that patient had no other vaccine in four weeks, patient did not have COVID prior vaccination and was not tested for covid post vaccination. On 13Feb2021 at 07:30 AM the patient experienced headache, sore/swollen throat (two days after injection). It was unknown if any treatment was received for event. The event outcome was unknown.  No follow-up attempts were possible. No further information was expected.
left shoulder pain, redness, warmth, itching starting 1/12/21.  Scheduled appointment for evaluation 1/14/21
2 days after injection patient reported to urgent care with worsening and spreading pain and redness at the site of injection.  She also had warmth and tenderness at the injection site.  She was diagnosed with cellulitis and treated with Cephalexin.
2 patches of hair loss on scalp. 3 in x 2 in near nape of neck and 1 in on top of head. No treatment started for his alopecia. Mom noted it 5/15/13. She is quite sure it was not there 6-8 weeks before that date.
pain in left arm from shoulder to elbow, limited range of motion in left arm, started within 12 hours of vaccination, still have same symptoms to date(May 6, 2021). Went to Dr, he ordered x-ray, couldn't tell much. Next was MRI and he said I had a rotator cuff damage - a full tear. Surgery is scheduled for June 24, 2021. Rehab will start after and continue for 10 to 12 months for full recovery hopefully.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY, SEQUELA PERIPHERAL NEUROPATHY